Christopher Trummer

Christopher Trummer leads Celeris Therapeutics, an AI-first drug discovery company specializing in proximity-inducing compounds. The company focuses on diseases with high unmet medical needs, like Parkinson's and various cancers. Using its Celeris One platform, it combines structure-based geometric deep learning with an automated lab for rapid experimental data generation. Trummer's role is pivota...